GlassScriptPhysician profile
Stacy L Sims
NPI 1689838146
$2,409.72
in general payments reported to CMS, 2019-2025
32 companies · $385 in 2025
The $385 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $373 · 2020: $210 · 2021: $202 · 2022: $425 · 2023: $468 · 2024: $347 · 2025: $385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,199.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $422.87 | 2019-2025 | Lo Loestrin Fe |
| Astellas Pharma US INC | $357.26 | 2019-2025 | Veozah, Myrbetriq |
| Evofem Biosciences, INC. | $176.15 | 2023-2025 | Phexxi, Solosec, Phexx |
| Pfizer INC. | $144.47 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $132.05 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $125.25 | 2019-2024 | |
| Organon LLC | $90.85 | 2023-2025 | Nexplanon |
| Daiichi Sankyo INC. | $80.93 | 2019-2022 | |
| Optumhealth Care Solutions, LLC | $74.24 | 2023-2025 | Vivify Health Care Team Portal 001, Eitan Medical, Zyno Solutions |
| Shield Therapeutics INC | $67.76 | 2024-2025 | |
| Scynexis, INC. | $64.48 | 2022 | |
| Biogen, INC. | $59.39 | 2025 | Zurzuvae |
| Allergan, INC. | $58.74 | 2019-2020 | |
| Therapeuticsmd, INC. | $54.45 | 2019 | |
| Hologic Sales and Service, LLC | $53.16 | 2023-2025 | Acessa Provu System, Aptima, Thinprep 2000 Processor |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $50.79 | 2019-2022 | |
| Avion Pharmaceuticals | $47.23 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $45.98 | 2023 | Myfembree |
| Merck Sharp & Dohme LLC | $40.98 | 2019-2023 | Gardasil 9 |
| Meditrina | $38.66 | 2022-2024 | |
| Smith+Nephew, INC. | $36.21 | 2019-2023 | Acticoat 4" X 4", Pico 7, Pico 14 |
| Duchesnay USA Incorporated | $34.18 | 2019 | |
| Gynesonics, INC. | $28.86 | 2022 | |
| Myovant Sciences INC. | $18.10 | 2022 | |
| Olympus America INC. | $16.82 | 2022 | |
| Lupin INC. | $15.37 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $14.96 | 2022 | |
| Aspira Women'S Health INC | $13.57 | 2021 | |
| Amag Pharmaceuticals, INC. | $12.50 | 2019 | |
| Agile Therapeutics, INC. | $12.45 | 2022 | |
| Vertical Pharmaceuticals, LLC | $12.44 | 2019 | |
| Channel Medsystems, INC. | $8.57 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacy Sims listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.